-
L Leenhardt,
F Borson-Chazot,
M Calzada,
B Carnaille,
A Charrié,
B Cochand-Priollet,
C Do Cao,
S Leboulleux, G Le Clech,
G Mansour,
F Menegaux,
H Monpeyssen,
J Orgiazzi,
A Rouxel,
J L Sadoul,
M Schlumberger,
J Tramalloni,
F Tranquart,
J L Wemeau
Annales d Endocrinologie 09/2011; 72(4 Suppl 1):H1-26. · 0.74 Impact Factor
-
L Leenhardt,
F Borson-Chazot,
M Calzada,
B Carnaille,
A Charrié,
B Cochand-Priollet,
C D Cao,
S Leboulleux, G Le Clech,
G Mansour,
F Menegaux,
H Monpeyssen,
J Orgiazzi,
A Rouxel,
J L Sadoul,
M Schlumberger,
J Tramalloni,
F Tranquart,
J L Wemeau
[show abstract]
[hide abstract]
ABSTRACT: Good practice guide for cervical ultrasound scan and echo-guided techniques in treating differentiated thyroid cancer of vesicular origin. American, European and French Recommendations for the treatment of differentiated vesicular thyroid cancer were recently published. Cervical ultrasound scanning is now considered a key examination in the follow-up of these cancers. This examination is noninvasive, easy to perform and to obtain, is not costly, but remains operator-dependent. To date, there are no recommendations published that assemble all the technical aspects, results, indications and the limits of this examination in the initial medical report and the follow-up of these cancers. In order to standardise the procedure and validate the quality of the examination, a workgroup made up of a panel of experts particularly involved in carrying out ultrasound scans was set up. The aim was to draw up a good practice guide for performing cervical ultrasound scans and echo-guided techniques in treating patients with differentiated thyroid cancer of vesicular origin. The main objectives are to: (a) standardise the procedure and reports, (b) define the criteria for establishing whether lesions identified during a cervical ultrasound scan are malignant or benign, (c) standardise the indications for carrying out cytological tests and an in situ assay of markers, (d) help doctors to select the patients who ought to receive a cervical ultrasound scan and or cytological tests, (e) discuss how frequently the examinations should be carried out depending on the risk of recurrence.
Annales d Endocrinologie 06/2011; 72(3):173-97. · 0.74 Impact Factor
-
F Borson-Chazot,
S Bardet,
C Bournaud,
B Conte-Devolx,
C Corone,
M D'Herbomez,
J-F Henry,
L Leenhardt,
J-L Peix,
M Schlumberger, [......],
I Raingeard,
P Rodien,
V Rohmer,
J-L Sadoul,
C Schwartz,
F Tenenbaum,
M-E Toubert,
J Tramalloni,
J-P Travagli,
C Vaudrey
Annales d Endocrinologie 01/2009; 69(6):472-86. · 0.74 Impact Factor
